Last reviewed · How we verify

intraarticular injection with ropivacaine

Hvidovre University Hospital · FDA-approved active Small molecule

intraarticular injection with ropivacaine is a Local anesthetic Small molecule drug developed by Hvidovre University Hospital. It is currently FDA-approved for Intra-articular anesthesia and analgesia for joint procedures and post-operative pain management.

Ropivacaine is a local anesthetic that blocks sodium channels in nerve fibers, preventing the initiation and propagation of action potentials to produce localized anesthesia and analgesia.

Ropivacaine is a local anesthetic that blocks sodium channels in nerve fibers, preventing the initiation and propagation of action potentials to produce localized anesthesia and analgesia. Used for Intra-articular anesthesia and analgesia for joint procedures and post-operative pain management.

At a glance

Generic nameintraarticular injection with ropivacaine
SponsorHvidovre University Hospital
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia/Pain Management
PhaseFDA-approved

Mechanism of action

Ropivacaine is an amide-type local anesthetic that reversibly inhibits sodium influx through voltage-gated sodium channels in nerve cell membranes. When administered intra-articularly, it diffuses into nearby nerve tissues and synovial structures, producing regional anesthesia and pain relief in the joint. This mechanism allows for perioperative pain control and post-operative analgesia without systemic effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about intraarticular injection with ropivacaine

What is intraarticular injection with ropivacaine?

intraarticular injection with ropivacaine is a Local anesthetic drug developed by Hvidovre University Hospital, indicated for Intra-articular anesthesia and analgesia for joint procedures and post-operative pain management.

How does intraarticular injection with ropivacaine work?

Ropivacaine is a local anesthetic that blocks sodium channels in nerve fibers, preventing the initiation and propagation of action potentials to produce localized anesthesia and analgesia.

What is intraarticular injection with ropivacaine used for?

intraarticular injection with ropivacaine is indicated for Intra-articular anesthesia and analgesia for joint procedures and post-operative pain management.

Who makes intraarticular injection with ropivacaine?

intraarticular injection with ropivacaine is developed and marketed by Hvidovre University Hospital (see full Hvidovre University Hospital pipeline at /company/hvidovre-university-hospital).

What drug class is intraarticular injection with ropivacaine in?

intraarticular injection with ropivacaine belongs to the Local anesthetic class. See all Local anesthetic drugs at /class/local-anesthetic.

What development phase is intraarticular injection with ropivacaine in?

intraarticular injection with ropivacaine is FDA-approved (marketed).

What are the side effects of intraarticular injection with ropivacaine?

Common side effects of intraarticular injection with ropivacaine include Local tissue irritation, Transient joint swelling, Systemic toxicity (if absorbed in high concentrations), Allergic reaction.

What does intraarticular injection with ropivacaine target?

intraarticular injection with ropivacaine targets Voltage-gated sodium channels and is a Local anesthetic.

Related